1. Home
  2. RNW vs PTGX Comparison

RNW vs PTGX Comparison

Compare RNW & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

N/A

Current Price

$6.83

Market Cap

2.5B

Sector

Utilities

ML Signal

N/A

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

N/A

Current Price

$139.08

Market Cap

9.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RNW
PTGX
Founded
2011
2006
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
9.3B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
RNW
PTGX
Price
$6.83
$139.08
Analyst Decision
Buy
Strong Buy
Analyst Count
4
13
Target Price
$7.64
★ $174.69
AVG Volume (30 Days)
★ 1.4M
535.2K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 2.35
Revenue
N/A
N/A
Revenue This Year
$24.92
$1,078.44
Revenue Next Year
$12.29
N/A
P/E Ratio
★ $14.63
$60.03
Revenue Growth
N/A
N/A
52 Week Low
$4.39
$62.24
52 Week High
$8.17
$160.81

Technical Indicators

Market Signals
Indicator
RNW
PTGX
Relative Strength Index (RSI) 61.72 44.31
Support Level $6.78 $132.37
Resistance Level $6.85 $142.20
Average True Range (ATR) 0.02 4.59
MACD -0.01 -0.44
Stochastic Oscillator 62.50 39.61

Price Performance

Historical Comparison
RNW
PTGX

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects. Additionally, it provides clean energy solutions and value-added energy offerings through digitalization, storage, and carbon market services that are increasingly integral to addressing climate change. The company has two reportable segments: Generation and sale of renewable power and Manufacturing of power equipment. The majority of its revenue is generated from the Generation and sale of renewable power segment, which reflects the revenue earned from its utility-scale wind energy projects, solar energy projects, and hydro energy projects. The Manufacturing of power equipment segment relates to the manufacturing of solar panels and modules. Geographically, all of its material revenues are generated from India.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: